November 3, 2021 - … 3, 2021 News Release General Late breaker will show ADUHELM™ effect on plasma pTau181 reduction, and its … in Phase 3 trials and approximately 1,700 patients in the ADUHELM (aducanumab-avwa) redosing trial, EMBARK. A late … important new data from over 7,000 plasma samples from the ADUHELM Phase 3 trials that, for the first time, examines the …